Research Lambda published a Phase 2/3 randomized study NCT07765433 testing a bispecific antibody ivonescimab in advanced biliary tract cancer patients with metastatic or locally advanced unresectable disease.

Research Lambda is a clinical trial intelligence company helping pharma, biotech, and health systems move from protocol to study startup faster — without the manual bottlenecks that have defined the industry for decades. Our platform applies AI to the hardest problems in clinical operations: protocol feasibility, site and PI identification, and study activation. Where traditional approaches rely on spreadsheets, institutional memory, and months of back-and-forth, Research Lambda delivers data-driven decisions in days. Behind the platform is a team of PhD data scientists and engineers with deep roots in healthcare AI — and a track record that includes research programs for DARPA and ARPA-H. We don't just apply models to clinical data; we understand the biology, the regulatory context, and the operational realities that make healthcare AI uniquely hard to get right. For organizations with problems that go beyond off-the-shelf tools, we also take on custom research engagements: real-world evidence analysis, clinical NLP, knowledge graph construction, and end-to-end AI system development built to government-grade rigor. Research Lambda is operated by Health Innovations Operating Company, LLC, a Delaware limited liability company. Clinical research moves too slowly. We're here to change that. 🔬 Protocol Intelligence | Site & PI Matching | Feasibility Automation | Custom Healthcare AI #ClinicalTrials #DrugDevelopment #HealthcareAI #ClinicalOperations #RealWorldEvidence #Pharma #Biotech #ClinicalResearch #AIinHealthcare #StudyStartup #DigitalHealth #PharmaTech

Founded 2024